IBDEI0RF ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,13225,2)
 ;;=^123931
 ;;^UTILITY(U,$J,358.3,13226,0)
 ;;=337.1^^65^784^38
 ;;^UTILITY(U,$J,358.3,13226,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13226,1,3,0)
 ;;=3^Periph Neuropathy Diabetes
 ;;^UTILITY(U,$J,358.3,13226,1,4,0)
 ;;=4^337.1
 ;;^UTILITY(U,$J,358.3,13226,2)
 ;;=^268435
 ;;^UTILITY(U,$J,358.3,13227,0)
 ;;=443.9^^65^784^39
 ;;^UTILITY(U,$J,358.3,13227,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13227,1,3,0)
 ;;=3^Periph Vascular Dis Nos
 ;;^UTILITY(U,$J,358.3,13227,1,4,0)
 ;;=4^443.9
 ;;^UTILITY(U,$J,358.3,13228,0)
 ;;=443.81^^65^784^40
 ;;^UTILITY(U,$J,358.3,13228,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13228,1,3,0)
 ;;=3^Periph Vascular Dz In Diab
 ;;^UTILITY(U,$J,358.3,13228,1,4,0)
 ;;=4^443.81
 ;;^UTILITY(U,$J,358.3,13229,0)
 ;;=996.66^^65^784^42
 ;;^UTILITY(U,$J,358.3,13229,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13229,1,3,0)
 ;;=3^Prosthesis, Infected
 ;;^UTILITY(U,$J,358.3,13229,1,4,0)
 ;;=4^996.66
 ;;^UTILITY(U,$J,358.3,13230,0)
 ;;=996.77^^65^784^43
 ;;^UTILITY(U,$J,358.3,13230,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13230,1,3,0)
 ;;=3^Prosthesis, Painful
 ;;^UTILITY(U,$J,358.3,13230,1,4,0)
 ;;=4^996.77
 ;;^UTILITY(U,$J,358.3,13231,0)
 ;;=337.21^^65^784^47
 ;;^UTILITY(U,$J,358.3,13231,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13231,1,3,0)
 ;;=3^Reflex Symp Dyst Up L
 ;;^UTILITY(U,$J,358.3,13231,1,4,0)
 ;;=4^337.21
 ;;^UTILITY(U,$J,358.3,13232,0)
 ;;=337.22^^65^784^45
 ;;^UTILITY(U,$J,358.3,13232,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13232,1,3,0)
 ;;=3^Reflex Symp Dyst Ll
 ;;^UTILITY(U,$J,358.3,13232,1,4,0)
 ;;=4^337.22
 ;;^UTILITY(U,$J,358.3,13233,0)
 ;;=337.29^^65^784^46
 ;;^UTILITY(U,$J,358.3,13233,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13233,1,3,0)
 ;;=3^Reflex Symp Dyst Oth Site
 ;;^UTILITY(U,$J,358.3,13233,1,4,0)
 ;;=4^337.29
 ;;^UTILITY(U,$J,358.3,13234,0)
 ;;=714.0^^65^784^48
 ;;^UTILITY(U,$J,358.3,13234,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13234,1,3,0)
 ;;=3^Rheumatoid Arthritis
 ;;^UTILITY(U,$J,358.3,13234,1,4,0)
 ;;=4^714.0
 ;;^UTILITY(U,$J,358.3,13235,0)
 ;;=701.4^^65^784^50
 ;;^UTILITY(U,$J,358.3,13235,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13235,1,3,0)
 ;;=3^Scar,Hypertrophic
 ;;^UTILITY(U,$J,358.3,13235,1,4,0)
 ;;=4^701.4
 ;;^UTILITY(U,$J,358.3,13236,0)
 ;;=709.2^^65^784^49
 ;;^UTILITY(U,$J,358.3,13236,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13236,1,3,0)
 ;;=3^Scar & Fibrosis Skin
 ;;^UTILITY(U,$J,358.3,13236,1,4,0)
 ;;=4^709.2
 ;;^UTILITY(U,$J,358.3,13237,0)
 ;;=715.90^^65^784^32
 ;;^UTILITY(U,$J,358.3,13237,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13237,1,3,0)
 ;;=3^Osteoarthros Nos-Unspec
 ;;^UTILITY(U,$J,358.3,13237,1,4,0)
 ;;=4^715.90
 ;;^UTILITY(U,$J,358.3,13238,0)
 ;;=719.00^^65^784^24
 ;;^UTILITY(U,$J,358.3,13238,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13238,1,3,0)
 ;;=3^Joint Effusion-Unspec
 ;;^UTILITY(U,$J,358.3,13238,1,4,0)
 ;;=4^719.00
 ;;^UTILITY(U,$J,358.3,13239,0)
 ;;=848.9^^65^784^53
 ;;^UTILITY(U,$J,358.3,13239,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13239,1,3,0)
 ;;=3^Sprain Nos
 ;;^UTILITY(U,$J,358.3,13239,1,4,0)
 ;;=4^848.9
 ;;^UTILITY(U,$J,358.3,13240,0)
 ;;=879.8^^65^784^31
 ;;^UTILITY(U,$J,358.3,13240,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13240,1,3,0)
 ;;=3^Open Wound Site Nos
 ;;^UTILITY(U,$J,358.3,13240,1,4,0)
 ;;=4^879.8
 ;;^UTILITY(U,$J,358.3,13241,0)
 ;;=781.92^^65^784^1
 ;;^UTILITY(U,$J,358.3,13241,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13241,1,3,0)
 ;;=3^Abnormal Posture
 ;;^UTILITY(U,$J,358.3,13241,1,4,0)
 ;;=4^781.92
 ;;^UTILITY(U,$J,358.3,13241,2)
 ;;=^322158
 ;;
 ;;$END ROU IBDEI0RF
